Latest News of AVIR
Atea Pharmaceuticals Inc (AVIR) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ...
The Phase 3 HCV trial design will address adherence issues with randomized trials and an active comparator. The company's plan aligns with FDA guidelines and PK profiles for the fixed-dose combination...
Atea Pharmaceuticals Inc (AVIR) Q2 2024 Earnings Call Highlights: Strong Financial Position and ...
Atea executives discuss payer dynamics for Hepatitis C, competition with Pfizer's Paxlovid, financial highlights, and updates on COVID-19 trials. The company maintains strong financials and strategic ...
How long does COVID live on surfaces? Experts answer your coronavirus FAQs.
The new COVID-19 strains XEC and MV-1 are rapidly spreading worldwide. XEC, a variant of Omicron, is expected to become dominant. Transmission occurs mainly through respiratory particles, and preventi...
-
Jason Kelce Reveals Why He Couldn't Turn Down the Chance to Arm Wrestle Team USA's Nicole Heavirland
By PEOPLE.com | 3 months agoJason Kelce reflects on his experience at the 2024 Paris Olympics, where he engaged in a viral arm wrestling match with Team USA rugby star Nicole Heavirland. Despite initial hesitation, Kelce embrace...
-
Jason Kelce Arm Wrestles with Team USA Rugby Star Nicole Heavirland as Wife Kylie Calls Him Out for Cheating
By PEOPLE.com | 3 months agoFormer Philadelphia Eagles center, Jason Kelce, beat Team USA women's rugby star Nicole Heavirland in an arm wrestling challenge. Despite the win, there were suggestions of rule-breaking. Kelce was de...
-
NIH-funded trial finds HIV drug abacavir linked to higher cardiovascular risk
By Yahoo! Finance | 3 months agoNIH-funded REPRIEVE trial finds that HIV drug abacavir is associated with a higher risk of cardiovascular events. A daily statin regimen was shown to reduce MACE risk by over one-third. Further resear...
-
UK MHRA approves Lupin and Zentiva's raltegravir for HIV
By Yahoo! Finance | 3 months agoThe UK MHRA has authorized Lupin Healthcare and Zentiva Pharma's generic raltegravir for HIV treatment in adults and children. The medication inhibits HIV replication, with bioequivalence to the brand...
-
Bats, Gene Editing & Bioweapons: Recent DARPA Experiments Raise Concerns Amid Coronavirus Outbreak
By The Washington Standard | 5 months agoDARPA's recent experiments on bats, gene editing, and bioweapons have raised concerns amid the coronavirus outbreak. The agency's ties to developing a genetic material-based vaccine and its partnershi...